Literature DB >> 7737376

Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.

O Garred1, E Dubinina, P K Holm, S Olsnes, B van Deurs, J V Kozlov, K Sandvig.   

Abstract

Cleavage of Shiga toxin A-fragment at a highly trypsin-sensitive site increases its enzymatic activity. To investigate the role of this cleavage site in intoxication of cells, we studied the routing, cleavage, and toxicity of mutant toxin where the trypsin-sensitive site had been eliminated. Ultrastructural analysis of toxin tagged with horseradish peroxidase demonstrated that wild-type and mutant toxins were transported from endosomes to the trans-Golgi network and further through the Golgi cisterns to the endoplasmic reticulum. Wild-type toxin was much more efficient than the mutants in provoking rapid intoxication, but after prolonged incubation time also mutants were highly toxic. The cells were able to cleave both wild-type Shiga toxin and the mutants, but the cellular location for cleavage appears to differ. Wild-type toxin was cleaved in the presence of brefeldin A, which disrupts the Golgi cisterns. This indicates that the cleavage occurs in the endosomes or in the trans-Golgi network. In contrast, the mutant Shiga-His (R248H/R251H) was not cleaved in the presence of brefeldin A, indicating that the cleavage can occur only after the toxin has left the trans-Golgi network. In vitro experiments showed that the cytosolic enzyme calpain is able to cleave Shiga-His, and results from in vivo experiments are consistent with the possibility that cleavage is carried out by calpain after the mutant A-fragment has reached the cytosol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737376     DOI: 10.1006/excr.1995.1128

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 3.  Retrograde transport of protein toxins through the Golgi apparatus.

Authors:  Kirsten Sandvig; Tore Skotland; Bo van Deurs; Tove Irene Klokk
Journal:  Histochem Cell Biol       Date:  2013-06-14       Impact factor: 4.304

4.  Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum.

Authors:  K Sandvig; O Garred; B van Deurs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity.

Authors:  M L Suhan; C J Hovde
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease.

Authors:  C S Chen; G Bach; R E Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Modeling neutralization of Shiga 2 toxin by A-and B-subunit-specific human monoclonal antibodies.

Authors:  Vladas Skakauskas; Pranas Katauskis
Journal:  J Biol Phys       Date:  2016-05-07       Impact factor: 1.365

Review 8.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

9.  Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.

Authors:  K Sandvig; O Garred; A van Helvoort; G van Meer; B van Deurs
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

10.  In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.

Authors:  Kwang-il Jeong; Susan Chapman-Bonofiglio; Pradeep Singh; Jongo Lee; Saul Tzipori; Abhineet S Sheoran
Journal:  BMC Immunol       Date:  2010-03-24       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.